In their multicenter cohort, the loss of or a reduction in E-Cadherin expression was commonly observed, but no significant correlation was found between E-Cadherin status and key clinical parameters, such as tumor size, cavernous sinus invasion, recurrence risk, or granulation pattern [62]. This evidence concerns the gene CDH1 and neoplasm.